Trademark: 97459672
Word
O
Status Date
Tuesday, October 31, 2023
Registration Number
7205233
Registration Date
Tuesday, October 31, 2023
Filing Date
Wednesday, June 15, 2022
Published for Opposition
Tuesday, August 15, 2023
5 Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in identifying genetic markers for inherited diseases, genetic predispositions, and drug responses and for disease detection, namely, COVID-19, total cholesterol, HDL, LDL, total triglycerides, HbA1C, ALT, AST, and blood pressure
44 Providing health screening tests in the fields of infectious diseases, cardiovascular diseases, metabolic diseases, respiratory diseases, neurological diseases, renal diseases, cancer, genetic disorders, behavioral and mental health, and cancer risk assessments; medical information services, namely, reporting of authorized clinical testing results; DNA analysis and screening for diagnostic purposes and for the purpose of providing medical information; providing a website featuring medically relevant information regarding genetics and infectious diseases for educational purposes; providing health and wellness information and public health information in connection with infectious disease and genetics; genomics consulting services, namely, genetic counseling; consulting services in the fields of diagnostic medical testing
42 Genomic testing for scientific research purposes; providing online databases containing scientific and genomic information in the nature of results of sequencing genes of interest in the human genome; SaaS services, namely, software enabling individuals to view results of laboratory tests and informational reports; analysis of genetic information for scientific research purposes and for the purpose of providing individuals with scientific information about genetics; providing an online open database featuring scientific information about human genetics to enable researchers to understand human genetic information; SaaS services featuring software for performing health assessments and health screening tests; SaaS services featuring software for storing, tracking, managing, analyzing, reporting, and aggregating health screening results and public and personal health data; SaaS services featuring software for reviewing and accessing genetic sequencing information and for reviewing and accessing genetic sequencing analysis, and annotated results of health data and health screening results for purposes of enabling health initiatives and public health reporting; SaaS services featuring software for population data analysis, namely, software for use in testing for and vaccinating against communicable diseases, compliance, and demographics analysis
The mark consists of a stylized "O" design in which half of the "O" design is comprised of the colors yellow, purple, blue, and green. The other half of the "O" design appears in white and the center of the "O" design appears in black and is not part of the mark. The color black also represents the background and is not part of the mark.
The color(s) white, yellow, purple, blue, green is/are claimed as a feature of the mark.
Oct 31, 2023
Notice Of Registration Confirmation Emailed
Oct 31, 2023
Registered-Principal Register
Aug 15, 2023
Official Gazette Publication Confirmation E-Mailed
Aug 15, 2023
Published For Opposition
Jul 26, 2023
Notification Of Notice Of Publication E-Mailed
Jul 11, 2023
Approved For Pub - Principal Register
Jul 4, 2023
Teas/Email Correspondence Entered
Jul 3, 2023
Correspondence Received In Law Office
Jul 3, 2023
Teas Response To Office Action Received
Apr 6, 2023
Notification Of Non-Final Action E-Mailed
Apr 6, 2023
Non-Final Action E-Mailed
Apr 6, 2023
Non-Final Action Written
Mar 28, 2023
Assigned To Examiner
Sep 6, 2022
Teas Change Of Correspondence Received
Sep 6, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 6, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 29, 2022
New Application Office Supplied Data Entered
Jun 18, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
